Antibacterial spectrum and cytotoxic activities of serrulatane compounds from the Australian medicinal plant Eremophila neglecta

Journal of Applied Microbiology

Volumn 112, Issue 1, 2012, Pages 197-204

  Anakok, O F ^a   Ndi, C P ^a   Barton, D ^a   Griesser, H J ^a   Semple, S J ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Antimicrobial activity; Australian medicinal plants; Cytotoxicity; Eremophila neglecta; Myoporaceae; Serrulatane diterpenoids

Indexed keywords

ASSAYS; BACTERIA; CELL CULTURE; CELLS; MAMMALS; MEDICAL APPLICATIONS; PLANTS (BOTANY);

ANTI-MICROBIAL ACTIVITY; ANTIBACTERIALS; AUSTRALIAN MEDICINAL PLANT; CYTOTOXIC ACTIVITIES; DITERPENOIDS; EREMOPHILUM NEGLECTUM; MEDICINAL PLANTS; MYOPORACEAE; SERRULATANE DITERPENOID; SPECTRA'S;

CYTOTOXICITY;

8 HYDROXYSERRULAT 14 EN 19 OIC ACID; 8,19 DIHYDROXYSERRULAT 14 ENE; ANTIINFECTIVE AGENT; CYTOTOXIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOASSAY; CELL ORGANELLE; CONCENTRATION (COMPOSITION); DILUTION; INHIBITOR; MEDICINAL PLANT; ORGANIC COMPOUND; PATHOGENICITY; TOXICITY;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACILLUS SUBTILIS; BROTH DILUTION; CYTOTOXICITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EREMOPHILA (ANGIOSPERM); EREMOPHILA NEGLECTA; ERYSIPELOTHRIX RHUSIOPATHIAE; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; NONHUMAN; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VERO CELL;

AUSTRALIA;

BACTERIA (MICROORGANISMS); MAMMALIA; MORAXELLA CATARRHALIS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; NEGIBACTERIA; POSIBACTERIA; SCROPHULARIACEAE;

EID: 83555177268     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2011.05174.x     Document Type: Article

References (37)

1. AAMI - Association for the Advancement of Medical Instrumentation (1999) Biological Evaluation of Medical Devices. Part 5. Tests for In Vitro Cytotoxicity. ANSI/AAMI/ISO 10993-5:1999. Arlington: AAMI.
2. Barr, A. (1988) Traditional Bush Medicines: An Aboriginal Pharmacopoeia. Victoria, Australia: Greenhouse Publications.
3. Bell, J.M., Turnidge, J.D. and Jones, R.N. (2009) Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using Clinical and Laboratory Standards Institute Methods: a SENTRY Antimicrobial Surveillance Program Report. J Clin Microbiol 47, 2187-2193.
4. Chinnock, R.J. (2007) Eremophila and Allied Genera. Kenthurst, NSW: Rosenberg Publishing.
5. CLSI - Clinical and Laboratory Standards Institute (2009a) Performance Standards for Antimicrobial Susceptibility Testing. Nineteenth Informational Supplement. CLSI document M100-S19 Volume 29(3). Wayne, PA, USA: CLSI.
6. CLSI - Clinical and Laboratory Standards Institute (2009b) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, 3rd edn. CLSI document M31-A3 Volume 28(8). Wayne, PA, USA: CLSI.
7. Cos, P., Vlietinck, A.J., Berghe, D.V. and Maes, L. (2006) Anti-infective potential of natural products: how to develop a stronger in vitro proof-of-concept'. J Ethnopharmacol 106, 290-302.
8. Cowan, M.M. (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12, 564-582.
9. Cribb, A.B. and Cribb, J.W. (1981) Wild Medicine in Australia. Sydney: Collins.
10. Duwe, A.K., Rupar, C.A., Horsman, G.B. and Vas, S.I. (1986) In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide. Antimicrob Agents Chemother 30, 340-341.
11. Fenollar, F. and Raoult, D. (2000) Comparison of a commercial disk test with vancomycin and colimycin susceptibility testing for identification of bacteria with abnormal Gram staining reactions. Eur J Clin Microbiol Infect Dis 19, 33-38.
12. Fuchs, P.C., Barry, A.L. and Brown, S.D. (1998) PMX-622 (polymyxin B-dextran 70) does not alter in vitro activities of 11 antimicrobial agents. Antimicrob Agents Chemother 42, 2765-2767.
13. Ghisalberti, E.L. (1994a) The ethnopharmacology and phytochemistry of Eremophila species (Myoporaceae). J Ethnopharmacol 44, 1-9.
14. Ghisalberti, E.L. (1994b) The phytochemistry of the Myoporaceae. Phytochemistry 35, 7-33.
15. Latz, P.K. (1995) Bushfires & Bushtucker: Aboriginal Plant Use in Central Australia. Alice Springs: IAD Press.
16. Liu, Q., Harrington, D., Kohen, J.L., Vemulpad, S. and Jamie, J.F. (2006) Bactericidal and cyclooxygenase inhibitory diterpenes from Eremophila sturtii. Phytochemistry 67, 1256-1261.
17. Low, T. (1990) Bush Medicine: A Pharmacopoeia of Natural Remedies. North Ryde: Angus & Robertson.
18. Meilak, M. and Palombo, E.A. (2008) Anti-mycobacterial activity of extracts derived from Australian medicinal plants. Res J Microbiol 3, 535-538.
19. Ndi, C.P., Semple, S.J., Griesser, H.J. and Barton, M.D. (2007a) Antimicrobial activity of some Australian plant species from the genus Eremophila. J Basic Microbiol 47, 158-164.
20. Ndi, C.P., Semple, S.J., Griesser, H.J., Pyke, S.M. and Barton, M.D. (2007b) Antimicrobial compounds from Eremophila serrulata. Phytochemistry 68, 2684-2690.
21. Ndi, C.P., Semple, S.J., Griesser, H.J., Pyke, S.M. and Barton, M.D. (2007c) Antimicrobial compounds from the Australian desert plant Eremophila neglecta. J Nat Prod 70, 1439-1443.
22. O'Gara, J.P. and Humphreys, H. (2001) Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 50, 582-587.
23. Palombo, E.A. and Semple, S.J. (2001) Antibacterial activity of traditional Australian medicinal plants. J Ethnopharmacol 77, 151-157.
24. Palombo, E.A. and Semple, S.J. (2002) Antibacterial activity of Australian plant extracts against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). J Basic Microbiol 42, 444-448.
25. Pennacchio, M., Kemp, A.S., Taylor, R.P., Wickens, K.M. and Kienow, L. (2005) Interesting biological activities from plants traditionally used by Native Australians. J Ethnopharmacol 96, 597-601.
26. Rodríguez, A.D., Ramírez, C., Rodríguez, I.I. and González, E. (1999) Novel antimycobacterial benzoxazole alkaloids, from the West Indian Sea whip Pseudopterogorgia elisabethae. Org Lett 1, 527-530.
27. Rogers, K.L., Grice, I.D. and Griffiths, L.R. (2000) Inhibition of platelet aggregation and 5-HT release by extracts of Australian plants used traditionally as headache treatments. Eur J Pharm Sci 9, 355-363.
28. Rogers, K.L., Grice, I.D. and Griffiths, L.R. (2001) Modulation of in vitro platelet 5-HT release by species of Erythrina and Cymbopogon. Life Sci 69, 1817-1829.
29. + channels. Eur J Pharm Sci 15, 321-330.
30. Semple, S.J., Reynolds, G.D., O'Leary, M.C. and Flower, R.L.P. (1998) Screening of Australian medicinal plants for antiviral activity. J Ethnopharmacol 60, 163-172.
31. Smith, J.E., Tucker, D., Watson, K. and Jones, G.L. (2007) Identification of antibacterial constituents from the indigenous Australian medicinal plant Eremophila duttonii F. Muell. (Myoporaceae). J Ethnopharmacol 112, 386-393.
32. Sweeney, A.P., Wyllie, S.G., Shalliker, R.A. and Markham, J.L. (2001) Xanthine oxidase inhibitory activity of selected Australian native plants. J Ethnopharmacol 75, 273-277.
33. Sweetman, S. (2010) Martindale. The Complete Drug Reference (online). London: Pharmaceutical Press. Available at: (accessed 13 August 2010).
34. Vasilev, K., Griesser, S.S., Ndi, C., Ys, H. and Griesser, H.J. (2010) Mammalian Cell Responses to Antibacterial Coatings Comprising Silver Nanoparticles in Plasma Polymers. Brisbane: Proceedings Ann Mtg Aust Soc Biomaterials, February 2010.
35. Verduin, C.M., Hol, C., Fleer, A., van Dijk, H. and van Belkum, A. (2002) Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev 15, 125-144.
36. Yang, G., Pevear, D.C., Davies, M.H., Collett, M.S., Bailey, T., Rippen, S., Barone, L., Burns, C. et al. (2005) An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 79, 13139-13149.
37. Zambon, J.J. and Kasprzak, S.A. (1995) The microbiology and histopathology of human root caries. Am J Dent 8, 323-328.